Article | September 17, 2020

Designing A Facility For Vaccine Production

By Robert L. Roy, IPS

Vials Pharma Manufacturing

Building a facility to produce vaccines is among the most challenging endeavors an organization can undertake. Timelines are long, budgets are likely to be tight, and the technology is ever-changing.

IPS designs up to a dozen such facilities every year, leveraging a blend of technical, healthcare, and architectural talent to create pharmaceutically elegant facility designs that meet customers’ production capacity, project timeline, and project budget objectives.

Here, we examine challenges faced by pharmaceutical companies when designing a facility to produce vaccines — be it an active pharmaceutical ingredient (API) manufacturing facility or an aseptic fill/finish facility. We also discuss how IPS can help customers overcome those challenges.

VIEW THE ARTICLE!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of Cell & Gene? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to:

IPS-Integrated Project Services